Stay updated on Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Sign up to get notified when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.

Latest updates to the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedFooter updates include the new 'Revision: v3.3.3' label and removal of the 'HHS Vulnerability Disclosure' and 'Revision: v3.3.2' notes. These changes are cosmetic and do not affect study data, eligibility, or navigation.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check47 days agoChange DetectedVersion history now adds an Oversight entry and a Study Status update (2025-11-17) with Revision: v3.3.2, and the prior Revision: v3.2.0 was deleted (2025-07-14).SummaryDifference0.5%

- Check54 days agoChange DetectedRemoval of the government funding lapse notice from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.6%

- Check68 days agoChange DetectedThe old and new screenshots display the same study record history content (study status entries, revisions, and locations) with no changes to core data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check97 days agoChange Detected- Added a government-funding notice about potential delays and updated operating status guidance, and a major version bump to v3.2.0. - Removed the previous version tag v3.1.0.SummaryDifference11%

- Check104 days agoChange Detected- Updated revision from v3.0.2 to v3.1.0. This indicates a new version release, but does not imply substantive changes to core content or functionality based on the provided additions/deletions.SummaryDifference0.3%

Stay in the know with updates to Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Adagrasib in Elderly/Poor Performance KRASG12C NSCLC Clinical Trial page.